GKB Ophthalmics receives Rs 8.82 Cr demand notice from Labour Commissioner

1 min read     Updated on 14 Jul 2026, 02:09 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

GKB Ophthalmics Ltd received a Notice of Demand on July 13, 2026, for Rs 8.82 Cr following a Labour Commissioner order dated September 04, 2025. The company plans to challenge the order in the Bombay High Court. The demand is linked to a 2021 Industrial Tribunal award currently under litigation.

powered bylight_fuzz_icon
45563927

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics Ltd received a Notice of Demand from the Office of the Mamlatdar of Bardez Taluka, Mapusa, Goa on July 13, 2026, requiring the payment of Rs 8.82 Cr within 10 days. This demand arises from an order passed by the Labour Commissioner on September 04, 2025, for the recovery of funds from the company. The company intends to challenge the order before the Hon'ble High Court of Bombay by filing a writ petition seeking appropriate relief.

The development is related to ongoing litigation concerning an award passed by the Industrial Tribunal Panjim-Goa on May 25, 2021. The company is currently challenging this award through writ petition no. WP/358/2021 before the Hon'ble High Court of Bombay at Goa. Simultaneously, the matter was pending execution before the Labour Commissioner, leading to the recovery order and the subsequent demand notice.

The disclosure was made to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation references SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Details of the Demand

The notice specifies a recovery amount of Rs 8.82 Cr and sets a strict deadline for payment. The company has clarified that it will consult with its legal counsel to contest the demand.

Particulars Details
Authority Office of the Mamlatdar of Bardez Taluka, Mapusa, Goa
Date of Notice July 13, 2026
Amount Demanded Rs 8.82 Cr
Payment Deadline Within 10 days from July 13, 2026
Underlying Order Labour Commissioner Order dated September 04, 2025

Legal Proceedings

The company is actively involved in legal proceedings regarding the original award by the Industrial Tribunal. The filing of a new writ petition to challenge the recovery order represents the latest step in its legal strategy to manage the financial and operational implications of the case.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
-3.56%+0.88%-6.64%+13.88%-23.08%-36.35%

How will the immediate cash flow requirement of Rs 8.82 Cr impact GKB Ophthalmics' operational liquidity and working capital management?

What is the likelihood of the Hon'ble High Court granting a stay on the recovery order before the 10-day payment deadline expires?

If the company is unsuccessful in its legal challenge, what potential assets or business segments could be leveraged to satisfy the debt?

Promoter group buys shares in GKB Ophthalmics worth ₹64,801.77

1 min read     Updated on 30 Jun 2026, 01:31 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Krishna Gopal Gupta & Sons (HUF), a promoter group entity, purchased 1,016 equity shares of GKB Ophthalmics Limited between June 8 and June 17, 2026. The transactions were executed on the BSE for an aggregate value of ₹64,801.77. The entity has agreed to hold the securities for a minimum period of six months.

powered bylight_fuzz_icon
44352098

*this image is generated using AI for illustrative purposes only.

Krishna Gopal Gupta & Sons (HUF), a promoter group entity, purchased 1,016 equity shares of GKB Ophthalmics Ltd between June 8 and June 17, 2026. The transactions were executed on the BSE for an aggregate value of ₹64,801.77. The disclosure was made pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The purchases were made on the open market across five separate trading days. The Karta of the HUF, K.G. Gupta, undertook to preserve transaction details for three years and agreed to hold the acquired securities for a minimum period of six months. The entity confirmed that the transactions did not exceed the threshold limit prescribed under the regulations but were disclosed as a corporate governance measure.

Transaction Details

The following table outlines the specific acquisitions made by the promoter group entity:

Date of Acquisition Shares Purchased Transaction Value (₹) Total Holdings Post-Acquisition Holding Percentage
08/06/2026 50 3,209.82 300,103 5.95%
09/06/2026 147 9,222.68 300,250 5.95%
11/06/2026 160 10,272.24 300,410 5.95%
12/06/2026 343 21,987.94 300,753 5.96%
17/06/2026 316 20,109.09 301,069 5.97%

The intimation regarding these transactions was submitted to the company on June 30, 2026. GKB Ophthalmics subsequently forwarded the disclosure to the Bombay Stock Exchange on the same day.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
-3.56%+0.88%-6.64%+13.88%-23.08%-36.35%

Does this incremental increase in promoter holdings signal a potential larger stake acquisition strategy in the near future?

How might the market interpret this insider buying regarding GKB Ophthalmics' upcoming quarterly earnings performance?

Will other promoter group entities follow suit with similar open market purchases to consolidate their position?

More News on GKB Ophthalmics

1 Year Returns:-23.08%